Some methods comprise identifying chemical candidates that modulate oligomerization of FOXP3 and / or fragments thereof comprising the Zinc-LeuZip domains. Other methods comprise determining chemical candidates. That modulate interaction of IL-2 promoter with FOXP3, or. Those that modulate transcriptional repression of transcription. The present invention relates to methods of treating individuals who have or are suspected of having autoimmune disease, inflammatory disease, cell, tissue or organ transplant
Some methods comprise identifying chemical candidates that modulate oligomerization of FOXP3 and / or fragments thereof comprising the Zinc-LeuZip domains. Other methods comprise determining chemical candidates. That modulate interaction of IL-2 promoter with FOXP3, or. Those that modulate transcriptional repression of transcription. The present invention relates to methods of treating individuals who have or are suspected of having autoimmune disease, inflammatory disease, cell, tissue or organ transplant
Some methods comprise identifying chemical candidates that modulate oligomerization of FOXP3 and / or fragments thereof comprising the Zinc-LeuZip domains. Other methods comprise determining chemical candidates. That modulate interaction of IL-2 promoter with FOXP3, or. Those that modulate transcriptional repression of transcription. The present invention relates to methods of treating individuals who have or are suspected of having autoimmune disease, inflammatory disease, cell, tissue or organ transplant
Methods of identifying immune response modulators are disclosed. Some methods
comprise identifying chemical candidates that modulate oligomerization of FOXP3 and/or fragments thereof comprising the Zinc-LeuZip domains. Some methods comprise identifying chemical candidates that modulate the hetero-oligomerization of FOXP1 with FOXP3 and/or fragments thereof comprising the Zinc-LeuZip domains. Some methods comprise identifying chemical candidates that modulate interaction of IL-2 promoter with FOXP3 and/or fragments thereof comprising the Zinc-LeuZip domains. Method of treating individuals who have or are suspected of having autoimmune disease, inflammatory disease, cell, tissue or organ transplantation, or coronary artery disease, and methods of treating individuals who have or are suspected of having infectious disease, cancer, or who are immunocompromised or undergoing vaccination
Other References
Lopes, J.E., et al. Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor. Journal of Immunology, 2006, vol. 177, p. 3133-3142. cited by examiner . Schubert, L.A., et al. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem., 2001, vol. 276, No. 40, p. 37672-37679. cited by examiner . Li et al., "FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression" PNAS USA, Mar. 13, 2007, 104(11), 4571-4576. cited by applicant . Li et al., "FOXP3 ensembles in T-cell regulation", Immunol Reviews, Aug. 2006, 212, 99-113. cited by applicant . GenBank Accession No. EF534714, "Homo sapiens FOXP3 mRNA, complete cds", May 9, 2007. cited by applicant . GenBank Accession No. CAG33445, "Homo sapiens (human) hypothetical protein", Jun. 3, 2004. cited by applicant . GenBank Accession No. AAG47634, "FOXP1 [Homo sapiens]", Jan. 11, 2002. cited by applicant . GenBank Accession No. AAG47633, "FOXP1 [Homo sapiens]", Jan. 11, 2002. cited by applicant . GenBank Accession No. AAG47632, "FOXP1 [Homo sapiens]", Jan. 11, 2002. cited by applicant . GenBank Accession No. AAI31721, "FOXP1 protein [Homo sapiens]", Feb. 28, 2007. cited by applicant . GenBank Accession No. AAK69408, "transcription factor FOXP1 [Homo sapiens]", Jan. 11, 2002. cited by applicant . GenBank Accession No. BC080521, "Homo sapiens forkhead box P1, mRNA (cDNA clone IMAGE:3537750), complete cds", Jul. 15, 2006. cited by applicant . GenBank Accession No. BC071893, "Homo sapiens forkhead box P1, mRNA (cDNA clone IMAGE:3537501),complete cds", Jul. 15, 2006. cited by applicant . GenBank Accession No. BC054815, "Homo sapiens forkhead box P1, mRNA (cDNA clone IMAGE:5017122), complete cds", Jul. 15, 2006. cited by applicant . GenBank Accession No. BC005055, "Homo sapiens forkhead box P1, mRNA (cDNA clone IMAGE:2823199), complete cds", Jul. 15, 2006. cited by applicant . GenBank Accession No. ABQ15210, "FOXP3 [Homo sapiens]", May 9, 2007. cited by applicant . GenBank Accession No. AJ006884, "Homo sapiens IL-2 promoter and leader sequence", Nov. 14, 2006. cited by applicant . GenBank Accession No. X00695, "Human interleukin-2 (IL-2) gene and 5'-flanking region", Feb. 10, 1999. cited by applicant